Evidence map›Paper›PMID 36450270›Full record

ArticleEuropean addiction research2023

COVID-19-Related Death in Patients with Alcohol or Substance Use Disorders.

Raimondo Maria Pavarin, Dario Consonni, Fabio Lucchi, Paolo Pandolfi, Silvia Marani, Francesco Palmese, Marco Domenicali

Abstract readNews
In one paragraph

Article in European addiction research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Raimondo Maria PavarinEpidemiological Monitoring Center on Addiction, Azienda USL Bologna, Department of Mental Health and Addictions, Azienda USL Bologna, Bologna, Italy.
Dario ConsonniEpidemiology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Fabio LucchiDepartment of Mental Health and Addictions, Azienda USL di Bologna, Bologna, Italy.
Paolo PandolfiPublic Health Department, Azienda USL Bologna, Bologna, Italy.
Silvia MaraniEpidemiological Monitoring Center on Addiction, Azienda USL Bologna, Department of Mental Health and Addictions, Azienda USL Bologna, Bologna, Italy.
Francesco PalmeseDepartment of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Marco DomenicaliDepartment of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPeople with substance or alcohol use disorders (SUDs/AUDs) are likely to be more vulnerable to COVID-19 infection than the general population, but the evidence of COVID-19-related mortality in these patients is unclear.

objectivesThe aim of the study was to verify whether patients with AUD and SUD have a higher mortality rate for COVID-19-related mortality compared to the general population.

methodWe performed a follow-up study to assess mortality in 2020 in a cohort of patients diagnosed for the first time with AUDs or SUDs at the Public Health Services in the metropolitan area of Bologna (Northern Italy) from 2009 to 2019.

resultsSUDs/AUDs patients present an excess mortality with respect to the general population for all causes of death and for COVID-19-related mortality.

conclusionsOur data support the need for prevention strategies in SUDs/AUDs patients such as vaccinations.

Indexed as

AlcoholismCOVID-19Substance-Related DisordersFollow-Up StudiesHumansItalyAlcohol use disorderCohort studyCOVID-19MortalitySubstance use disorder

Identifiers

PMID36450270
PMCPMC9892992

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.